Medicare Enrolled

Dr. Jayne Bird, MD

Optician · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1516 LOCUST ST, Philadelphia, PA 19102
2155455458
Registered in NPPES since 2011
NPI: 1871887620 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bird from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bird? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bird

Dr. Jayne Bird is an optician specialist in Philadelphia, PA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Bird performed 646 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Bird received a total of $4,186 from 28 pharmaceutical and/or device companies across 197 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bird is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ Top 43% volume in PA $4,186 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
646
Medicare services
Top 43% in PA for optician
Not available
Unique patients (not deduplicated)
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
257 $5 $11
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
68 $65 $143
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
59 $75 $164
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
59 $41 $108
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
40 $90 $184
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $82 $201
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $110 $262
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
29 $66 $178
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
25 $43 $81
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
21 $137 $273
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $47 $90
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,186
Total received (2018-2024)
Avg $598/year across 7 years
Top 26% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
197
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,491
2023
$1,131
2022
$418
2021
$413
2020
$51
2019
$256
2018
$427

Payments by company (2024)

ABBVIE INC.
$377
E.R. Squibb & Sons, L.L.C.
$171
Incyte Corporation
$148
Dermavant Sciences, Inc.
$147
LEO Pharma Inc.
$110
GENZYME CORPORATION
$98
SUN PHARMACEUTICAL INDUSTRIES INC.
$67
Lilly USA, LLC
$66
Amgen Inc.
$65
Arcutis Biotherapeutics, Inc.
$64
Janssen Biotech, Inc.
$58
PFIZER INC.
$55
MAYNE PHARMA COMMERCIAL LLC
$51
Verrica Pharmaceuticals Inc.
$14
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$577
ABBVIE INC.
$498
AbbVie Inc.
$330
MAYNE PHARMA COMMERCIAL LLC
$329
E.R. Squibb & Sons, L.L.C.
$314
Incyte Corporation
$260
LEO Pharma Inc.
$245
GENZYME CORPORATION
$220
Dermavant Sciences, Inc.
$204
Janssen Biotech, Inc.
$154
PFIZER INC.
$149
Amgen Inc.
$132
Arcutis Biotherapeutics, Inc.
$125
Regeneron Healthcare Solutions, Inc.
$114
SUN PHARMACEUTICAL INDUSTRIES INC.
$109
Sun Pharmaceutical Industries Inc.
$90
Lilly USA, LLC
$83
Celgene Corporation
$46
Ortho Dermatologics, a division of Bausch Health US, LLC
$43
Almirall LLC
$23
Galderma Laboratories, L.P.
$23
Allergan, Inc.
$22
AbbVie, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
Helsinn Therapeutics (U.S.), Inc.
$16
Journey Medical Corporation
$14
Verrica Pharmaceuticals Inc.
$14
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · BOTOX COSMETIC · CIBINQO · COSENTYX · DUPIXENT · ENSTILAR · EUCRISA · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · LITFULO · OPZELURA · Otezla · RINVOQ · SKYRIZI · STELARA · Seysara · Sotyktu · TALTZ · TREMFYA · VALCHLOR · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Philadelphia?
Compare opticians in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
746
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.4 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bird is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bird experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Bird performed 257 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bird receive payments from pharmaceutical companies?
Yes. Dr. Bird received a total of $4,186 from 28 companies across 197 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bird's costs compare to other opticians in Philadelphia?
Dr. Bird's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bird) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →